Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Health
Genera Biosystems Limited (GBI) is a molecular diagnostics company that develops, manufactures and distributes multiplexed molecular diagnostics (MDx) test solutions which are based on patented Ampasand silica bead based testing platform. Its first products developed using its proprietary Ampasand platform are PapType, and RTIplex, that are registered and sold in Australia and the EU. Former Names --
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
We don't have access to this information yet.
Health
Genera Biosystems Limited (GBI) is a molecular diagnostics company that develops, manufactures and distributes multiplexed molecular diagnostics (MDx) test solutions which are based on patented Ampasand silica bead based testing platform. Its first products developed using its proprietary Ampasand platform are PapType, and RTIplex, that are registered and sold in Australia and the EU. Former Names --
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:GBI is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia